Mesoblast Limited
Mesoblast Limited MSB.AX Peers
See (MSB.AX) competitors and their performances in Stock Market.
Peer Comparison Table: Biotechnology Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| MSB.AX | $1.73 | +1.17% | 2.20B | -12.32 | -$0.14 | N/A |
| CSL.AX | $235.14 | -1.74% | 113.86B | 28.09 | $8.37 | +1.81% |
| TLX.AX | $24.47 | -8.69% | 8.27B | 174.79 | $0.14 | N/A |
| NEU.AX | $12.02 | -9.56% | 1.50B | 11.03 | $1.09 | N/A |
| BOT.AX | $0.41 | -12.90% | 791.35M | -20.25 | -$0.02 | N/A |
| OPT.AX | $0.60 | N/A | 738.77M | -1.36 | -$0.44 | N/A |
| PYC.AX | $1.23 | -1.60% | 717.41M | -11.18 | -$0.11 | N/A |
| CU6.AX | $2.22 | -8.64% | 713.40M | -13.88 | -$0.16 | N/A |
| CUV.AX | $10.98 | -3.00% | 550.36M | 14.26 | $0.77 | +0.46% |
| IMM.AX | $0.29 | -1.69% | 423.51M | -7.25 | -$0.04 | N/A |
Stock Comparison
MSB.AX vs CSL.AX Comparison
MSB.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSB.AX stands at 2.20B. In comparison, CSL.AX has a market cap of 113.86B. Regarding current trading prices, MSB.AX is priced at $1.73, while CSL.AX trades at $235.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSB.AX currently has a P/E ratio of -12.32, whereas CSL.AX's P/E ratio is 28.09. In terms of profitability, MSB.AX's ROE is -0.22%, compared to CSL.AX's ROE of +0.15%. Regarding short-term risk, MSB.AX is more volatile compared to CSL.AX. This indicates potentially higher risk in terms of short-term price fluctuations for MSB.AX.
MSB.AX vs TLX.AX Comparison
MSB.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSB.AX stands at 2.20B. In comparison, TLX.AX has a market cap of 8.27B. Regarding current trading prices, MSB.AX is priced at $1.73, while TLX.AX trades at $24.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSB.AX currently has a P/E ratio of -12.32, whereas TLX.AX's P/E ratio is 174.79. In terms of profitability, MSB.AX's ROE is -0.22%, compared to TLX.AX's ROE of +0.06%. Regarding short-term risk, MSB.AX is less volatile compared to TLX.AX. This indicates potentially lower risk in terms of short-term price fluctuations for MSB.AX.
MSB.AX vs NEU.AX Comparison
MSB.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSB.AX stands at 2.20B. In comparison, NEU.AX has a market cap of 1.50B. Regarding current trading prices, MSB.AX is priced at $1.73, while NEU.AX trades at $12.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSB.AX currently has a P/E ratio of -12.32, whereas NEU.AX's P/E ratio is 11.03. In terms of profitability, MSB.AX's ROE is -0.22%, compared to NEU.AX's ROE of +0.49%. Regarding short-term risk, MSB.AX is less volatile compared to NEU.AX. This indicates potentially lower risk in terms of short-term price fluctuations for MSB.AX.
MSB.AX vs BOT.AX Comparison
MSB.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSB.AX stands at 2.20B. In comparison, BOT.AX has a market cap of 791.35M. Regarding current trading prices, MSB.AX is priced at $1.73, while BOT.AX trades at $0.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSB.AX currently has a P/E ratio of -12.32, whereas BOT.AX's P/E ratio is -20.25. In terms of profitability, MSB.AX's ROE is -0.22%, compared to BOT.AX's ROE of -0.39%. Regarding short-term risk, MSB.AX is less volatile compared to BOT.AX. This indicates potentially lower risk in terms of short-term price fluctuations for MSB.AX.
MSB.AX vs OPT.AX Comparison
MSB.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSB.AX stands at 2.20B. In comparison, OPT.AX has a market cap of 738.77M. Regarding current trading prices, MSB.AX is priced at $1.73, while OPT.AX trades at $0.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSB.AX currently has a P/E ratio of -12.32, whereas OPT.AX's P/E ratio is -1.36. In terms of profitability, MSB.AX's ROE is -0.22%, compared to OPT.AX's ROE of +5.43%. Regarding short-term risk, MSB.AX is more volatile compared to OPT.AX. This indicates potentially higher risk in terms of short-term price fluctuations for MSB.AX.
MSB.AX vs PYC.AX Comparison
MSB.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSB.AX stands at 2.20B. In comparison, PYC.AX has a market cap of 717.41M. Regarding current trading prices, MSB.AX is priced at $1.73, while PYC.AX trades at $1.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSB.AX currently has a P/E ratio of -12.32, whereas PYC.AX's P/E ratio is -11.18. In terms of profitability, MSB.AX's ROE is -0.22%, compared to PYC.AX's ROE of -0.71%. Regarding short-term risk, MSB.AX is more volatile compared to PYC.AX. This indicates potentially higher risk in terms of short-term price fluctuations for MSB.AX.
MSB.AX vs CU6.AX Comparison
MSB.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSB.AX stands at 2.20B. In comparison, CU6.AX has a market cap of 713.40M. Regarding current trading prices, MSB.AX is priced at $1.73, while CU6.AX trades at $2.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSB.AX currently has a P/E ratio of -12.32, whereas CU6.AX's P/E ratio is -13.88. In terms of profitability, MSB.AX's ROE is -0.22%, compared to CU6.AX's ROE of -0.36%. Regarding short-term risk, MSB.AX is less volatile compared to CU6.AX. This indicates potentially lower risk in terms of short-term price fluctuations for MSB.AX.
MSB.AX vs CUV.AX Comparison
MSB.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSB.AX stands at 2.20B. In comparison, CUV.AX has a market cap of 550.36M. Regarding current trading prices, MSB.AX is priced at $1.73, while CUV.AX trades at $10.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSB.AX currently has a P/E ratio of -12.32, whereas CUV.AX's P/E ratio is 14.26. In terms of profitability, MSB.AX's ROE is -0.22%, compared to CUV.AX's ROE of +0.18%. Regarding short-term risk, MSB.AX is more volatile compared to CUV.AX. This indicates potentially higher risk in terms of short-term price fluctuations for MSB.AX.
MSB.AX vs IMM.AX Comparison
MSB.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSB.AX stands at 2.20B. In comparison, IMM.AX has a market cap of 423.51M. Regarding current trading prices, MSB.AX is priced at $1.73, while IMM.AX trades at $0.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSB.AX currently has a P/E ratio of -12.32, whereas IMM.AX's P/E ratio is -7.25. In terms of profitability, MSB.AX's ROE is -0.22%, compared to IMM.AX's ROE of -0.35%. Regarding short-term risk, MSB.AX is less volatile compared to IMM.AX. This indicates potentially lower risk in terms of short-term price fluctuations for MSB.AX.
MSB.AX vs DXB.AX Comparison
MSB.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSB.AX stands at 2.20B. In comparison, DXB.AX has a market cap of 343.74M. Regarding current trading prices, MSB.AX is priced at $1.73, while DXB.AX trades at $0.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSB.AX currently has a P/E ratio of -12.32, whereas DXB.AX's P/E ratio is -15.25. In terms of profitability, MSB.AX's ROE is -0.22%, compared to DXB.AX's ROE of -1.84%. Regarding short-term risk, MSB.AX is less volatile compared to DXB.AX. This indicates potentially lower risk in terms of short-term price fluctuations for MSB.AX.
MSB.AX vs OCC.AX Comparison
MSB.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSB.AX stands at 2.20B. In comparison, OCC.AX has a market cap of 324.25M. Regarding current trading prices, MSB.AX is priced at $1.73, while OCC.AX trades at $1.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSB.AX currently has a P/E ratio of -12.32, whereas OCC.AX's P/E ratio is -67.00. In terms of profitability, MSB.AX's ROE is -0.22%, compared to OCC.AX's ROE of -0.27%. Regarding short-term risk, MSB.AX is less volatile compared to OCC.AX. This indicates potentially lower risk in terms of short-term price fluctuations for MSB.AX.
MSB.AX vs RAC.AX Comparison
MSB.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSB.AX stands at 2.20B. In comparison, RAC.AX has a market cap of 231.06M. Regarding current trading prices, MSB.AX is priced at $1.73, while RAC.AX trades at $1.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSB.AX currently has a P/E ratio of -12.32, whereas RAC.AX's P/E ratio is -26.60. In terms of profitability, MSB.AX's ROE is -0.22%, compared to RAC.AX's ROE of -0.39%. Regarding short-term risk, MSB.AX is less volatile compared to RAC.AX. This indicates potentially lower risk in terms of short-term price fluctuations for MSB.AX.
MSB.AX vs IMU.AX Comparison
MSB.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSB.AX stands at 2.20B. In comparison, IMU.AX has a market cap of 164.27M. Regarding current trading prices, MSB.AX is priced at $1.73, while IMU.AX trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSB.AX currently has a P/E ratio of -12.32, whereas IMU.AX's P/E ratio is -1.10. In terms of profitability, MSB.AX's ROE is -0.22%, compared to IMU.AX's ROE of -1.42%. Regarding short-term risk, MSB.AX is less volatile compared to IMU.AX. This indicates potentially lower risk in terms of short-term price fluctuations for MSB.AX.
MSB.AX vs PAR.AX Comparison
MSB.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSB.AX stands at 2.20B. In comparison, PAR.AX has a market cap of 120.72M. Regarding current trading prices, MSB.AX is priced at $1.73, while PAR.AX trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSB.AX currently has a P/E ratio of -12.32, whereas PAR.AX's P/E ratio is -6.20. In terms of profitability, MSB.AX's ROE is -0.22%, compared to PAR.AX's ROE of -0.54%. Regarding short-term risk, MSB.AX is less volatile compared to PAR.AX. This indicates potentially lower risk in terms of short-term price fluctuations for MSB.AX.
MSB.AX vs PAA.AX Comparison
MSB.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSB.AX stands at 2.20B. In comparison, PAA.AX has a market cap of 111.93M. Regarding current trading prices, MSB.AX is priced at $1.73, while PAA.AX trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSB.AX currently has a P/E ratio of -12.32, whereas PAA.AX's P/E ratio is -11.50. In terms of profitability, MSB.AX's ROE is -0.22%, compared to PAA.AX's ROE of -0.87%. Regarding short-term risk, MSB.AX is less volatile compared to PAA.AX. This indicates potentially lower risk in terms of short-term price fluctuations for MSB.AX.
MSB.AX vs ATH.AX Comparison
MSB.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSB.AX stands at 2.20B. In comparison, ATH.AX has a market cap of 109.53M. Regarding current trading prices, MSB.AX is priced at $1.73, while ATH.AX trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSB.AX currently has a P/E ratio of -12.32, whereas ATH.AX's P/E ratio is -0.60. In terms of profitability, MSB.AX's ROE is -0.22%, compared to ATH.AX's ROE of -1.83%. Regarding short-term risk, MSB.AX is less volatile compared to ATH.AX. This indicates potentially lower risk in terms of short-term price fluctuations for MSB.AX.
MSB.AX vs BIO.AX Comparison
MSB.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSB.AX stands at 2.20B. In comparison, BIO.AX has a market cap of 101.98M. Regarding current trading prices, MSB.AX is priced at $1.73, while BIO.AX trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSB.AX currently has a P/E ratio of -12.32, whereas BIO.AX's P/E ratio is -46.50. In terms of profitability, MSB.AX's ROE is -0.22%, compared to BIO.AX's ROE of +0.08%. Regarding short-term risk, MSB.AX is more volatile compared to BIO.AX. This indicates potentially higher risk in terms of short-term price fluctuations for MSB.AX.
MSB.AX vs ALA.AX Comparison
MSB.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSB.AX stands at 2.20B. In comparison, ALA.AX has a market cap of 99.45M. Regarding current trading prices, MSB.AX is priced at $1.73, while ALA.AX trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSB.AX currently has a P/E ratio of -12.32, whereas ALA.AX's P/E ratio is -8.40. In terms of profitability, MSB.AX's ROE is -0.22%, compared to ALA.AX's ROE of -0.55%. Regarding short-term risk, MSB.AX is less volatile compared to ALA.AX. This indicates potentially lower risk in terms of short-term price fluctuations for MSB.AX.
MSB.AX vs AGN.AX Comparison
MSB.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSB.AX stands at 2.20B. In comparison, AGN.AX has a market cap of 96.07M. Regarding current trading prices, MSB.AX is priced at $1.73, while AGN.AX trades at $0.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSB.AX currently has a P/E ratio of -12.32, whereas AGN.AX's P/E ratio is -15.00. In terms of profitability, MSB.AX's ROE is -0.22%, compared to AGN.AX's ROE of -0.39%. Regarding short-term risk, MSB.AX is more volatile compared to AGN.AX. This indicates potentially higher risk in terms of short-term price fluctuations for MSB.AX.
MSB.AX vs ACW.AX Comparison
MSB.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSB.AX stands at 2.20B. In comparison, ACW.AX has a market cap of 85.78M. Regarding current trading prices, MSB.AX is priced at $1.73, while ACW.AX trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSB.AX currently has a P/E ratio of -12.32, whereas ACW.AX's P/E ratio is -2.70. In terms of profitability, MSB.AX's ROE is -0.22%, compared to ACW.AX's ROE of -0.44%. Regarding short-term risk, MSB.AX is more volatile compared to ACW.AX. This indicates potentially higher risk in terms of short-term price fluctuations for MSB.AX.
MSB.AX vs RCE.AX Comparison
MSB.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSB.AX stands at 2.20B. In comparison, RCE.AX has a market cap of 81.16M. Regarding current trading prices, MSB.AX is priced at $1.73, while RCE.AX trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSB.AX currently has a P/E ratio of -12.32, whereas RCE.AX's P/E ratio is -3.33. In terms of profitability, MSB.AX's ROE is -0.22%, compared to RCE.AX's ROE of +2.47%. Regarding short-term risk, MSB.AX is less volatile compared to RCE.AX. This indicates potentially lower risk in terms of short-term price fluctuations for MSB.AX.
MSB.AX vs EZZ.AX Comparison
MSB.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSB.AX stands at 2.20B. In comparison, EZZ.AX has a market cap of 68.40M. Regarding current trading prices, MSB.AX is priced at $1.73, while EZZ.AX trades at $1.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSB.AX currently has a P/E ratio of -12.32, whereas EZZ.AX's P/E ratio is 6.90. In terms of profitability, MSB.AX's ROE is -0.22%, compared to EZZ.AX's ROE of +0.40%. Regarding short-term risk, MSB.AX is less volatile compared to EZZ.AX. This indicates potentially lower risk in terms of short-term price fluctuations for MSB.AX.
MSB.AX vs PIQ.AX Comparison
MSB.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSB.AX stands at 2.20B. In comparison, PIQ.AX has a market cap of 51.76M. Regarding current trading prices, MSB.AX is priced at $1.73, while PIQ.AX trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSB.AX currently has a P/E ratio of -12.32, whereas PIQ.AX's P/E ratio is -6.08. In terms of profitability, MSB.AX's ROE is -0.22%, compared to PIQ.AX's ROE of -0.96%. Regarding short-term risk, MSB.AX is more volatile compared to PIQ.AX. This indicates potentially higher risk in terms of short-term price fluctuations for MSB.AX.
MSB.AX vs RAD.AX Comparison
MSB.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSB.AX stands at 2.20B. In comparison, RAD.AX has a market cap of 49.01M. Regarding current trading prices, MSB.AX is priced at $1.73, while RAD.AX trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSB.AX currently has a P/E ratio of -12.32, whereas RAD.AX's P/E ratio is -0.35. In terms of profitability, MSB.AX's ROE is -0.22%, compared to RAD.AX's ROE of -1.03%. Regarding short-term risk, MSB.AX is less volatile compared to RAD.AX. This indicates potentially lower risk in terms of short-term price fluctuations for MSB.AX.
MSB.AX vs CYP.AX Comparison
MSB.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSB.AX stands at 2.20B. In comparison, CYP.AX has a market cap of 42.93M. Regarding current trading prices, MSB.AX is priced at $1.73, while CYP.AX trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSB.AX currently has a P/E ratio of -12.32, whereas CYP.AX's P/E ratio is -3.80. In terms of profitability, MSB.AX's ROE is -0.22%, compared to CYP.AX's ROE of -0.95%. Regarding short-term risk, MSB.AX is less volatile compared to CYP.AX. This indicates potentially lower risk in terms of short-term price fluctuations for MSB.AX.
MSB.AX vs PTX.AX Comparison
MSB.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSB.AX stands at 2.20B. In comparison, PTX.AX has a market cap of 41.07M. Regarding current trading prices, MSB.AX is priced at $1.73, while PTX.AX trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSB.AX currently has a P/E ratio of -12.32, whereas PTX.AX's P/E ratio is -5.10. In terms of profitability, MSB.AX's ROE is -0.22%, compared to PTX.AX's ROE of -0.42%. Regarding short-term risk, MSB.AX is less volatile compared to PTX.AX. This indicates potentially lower risk in terms of short-term price fluctuations for MSB.AX.
MSB.AX vs SPL.AX Comparison
MSB.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSB.AX stands at 2.20B. In comparison, SPL.AX has a market cap of 37.64M. Regarding current trading prices, MSB.AX is priced at $1.73, while SPL.AX trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSB.AX currently has a P/E ratio of -12.32, whereas SPL.AX's P/E ratio is -3.00. In terms of profitability, MSB.AX's ROE is -0.22%, compared to SPL.AX's ROE of -0.49%. Regarding short-term risk, MSB.AX is more volatile compared to SPL.AX. This indicates potentially higher risk in terms of short-term price fluctuations for MSB.AX.
MSB.AX vs ILA.AX Comparison
MSB.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSB.AX stands at 2.20B. In comparison, ILA.AX has a market cap of 34.69M. Regarding current trading prices, MSB.AX is priced at $1.73, while ILA.AX trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSB.AX currently has a P/E ratio of -12.32, whereas ILA.AX's P/E ratio is -5.50. In terms of profitability, MSB.AX's ROE is -0.22%, compared to ILA.AX's ROE of -1.20%. Regarding short-term risk, MSB.AX is less volatile compared to ILA.AX. This indicates potentially lower risk in terms of short-term price fluctuations for MSB.AX.
MSB.AX vs LCT.AX Comparison
MSB.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSB.AX stands at 2.20B. In comparison, LCT.AX has a market cap of 24.53M. Regarding current trading prices, MSB.AX is priced at $1.73, while LCT.AX trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSB.AX currently has a P/E ratio of -12.32, whereas LCT.AX's P/E ratio is N/A. In terms of profitability, MSB.AX's ROE is -0.22%, compared to LCT.AX's ROE of -0.54%. Regarding short-term risk, MSB.AX is more volatile compared to LCT.AX. This indicates potentially higher risk in terms of short-term price fluctuations for MSB.AX.
MSB.AX vs ADO.AX Comparison
MSB.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSB.AX stands at 2.20B. In comparison, ADO.AX has a market cap of 21.64M. Regarding current trading prices, MSB.AX is priced at $1.73, while ADO.AX trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSB.AX currently has a P/E ratio of -12.32, whereas ADO.AX's P/E ratio is -0.80. In terms of profitability, MSB.AX's ROE is -0.22%, compared to ADO.AX's ROE of -1.34%. Regarding short-term risk, MSB.AX is less volatile compared to ADO.AX. This indicates potentially lower risk in terms of short-term price fluctuations for MSB.AX.
MSB.AX vs ATX.AX Comparison
MSB.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSB.AX stands at 2.20B. In comparison, ATX.AX has a market cap of 21.34M. Regarding current trading prices, MSB.AX is priced at $1.73, while ATX.AX trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSB.AX currently has a P/E ratio of -12.32, whereas ATX.AX's P/E ratio is -1.83. In terms of profitability, MSB.AX's ROE is -0.22%, compared to ATX.AX's ROE of -0.51%. Regarding short-term risk, MSB.AX is more volatile compared to ATX.AX. This indicates potentially higher risk in terms of short-term price fluctuations for MSB.AX.
MSB.AX vs NOX.AX Comparison
MSB.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSB.AX stands at 2.20B. In comparison, NOX.AX has a market cap of 21.04M. Regarding current trading prices, MSB.AX is priced at $1.73, while NOX.AX trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSB.AX currently has a P/E ratio of -12.32, whereas NOX.AX's P/E ratio is -7.20. In terms of profitability, MSB.AX's ROE is -0.22%, compared to NOX.AX's ROE of -0.47%. Regarding short-term risk, MSB.AX is less volatile compared to NOX.AX. This indicates potentially lower risk in terms of short-term price fluctuations for MSB.AX.
MSB.AX vs NYR.AX Comparison
MSB.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSB.AX stands at 2.20B. In comparison, NYR.AX has a market cap of 21.03M. Regarding current trading prices, MSB.AX is priced at $1.73, while NYR.AX trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSB.AX currently has a P/E ratio of -12.32, whereas NYR.AX's P/E ratio is -5.00. In terms of profitability, MSB.AX's ROE is -0.22%, compared to NYR.AX's ROE of -0.73%. Regarding short-term risk, MSB.AX is less volatile compared to NYR.AX. This indicates potentially lower risk in terms of short-term price fluctuations for MSB.AX.
MSB.AX vs KZA.AX Comparison
MSB.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSB.AX stands at 2.20B. In comparison, KZA.AX has a market cap of 18.91M. Regarding current trading prices, MSB.AX is priced at $1.73, while KZA.AX trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSB.AX currently has a P/E ratio of -12.32, whereas KZA.AX's P/E ratio is -0.73. In terms of profitability, MSB.AX's ROE is -0.22%, compared to KZA.AX's ROE of -1.33%. Regarding short-term risk, MSB.AX is less volatile compared to KZA.AX. This indicates potentially lower risk in terms of short-term price fluctuations for MSB.AX.
MSB.AX vs BTC.AX Comparison
MSB.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSB.AX stands at 2.20B. In comparison, BTC.AX has a market cap of 17.89M. Regarding current trading prices, MSB.AX is priced at $1.73, while BTC.AX trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSB.AX currently has a P/E ratio of -12.32, whereas BTC.AX's P/E ratio is 5.50. In terms of profitability, MSB.AX's ROE is -0.22%, compared to BTC.AX's ROE of +0.58%. Regarding short-term risk, MSB.AX is less volatile compared to BTC.AX. This indicates potentially lower risk in terms of short-term price fluctuations for MSB.AX.
MSB.AX vs IMC.AX Comparison
MSB.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSB.AX stands at 2.20B. In comparison, IMC.AX has a market cap of 16.83M. Regarding current trading prices, MSB.AX is priced at $1.73, while IMC.AX trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSB.AX currently has a P/E ratio of -12.32, whereas IMC.AX's P/E ratio is -2.40. In terms of profitability, MSB.AX's ROE is -0.22%, compared to IMC.AX's ROE of -0.64%. Regarding short-term risk, MSB.AX is more volatile compared to IMC.AX. This indicates potentially higher risk in terms of short-term price fluctuations for MSB.AX.
MSB.AX vs MDC.AX Comparison
MSB.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSB.AX stands at 2.20B. In comparison, MDC.AX has a market cap of 15.07M. Regarding current trading prices, MSB.AX is priced at $1.73, while MDC.AX trades at $6.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSB.AX currently has a P/E ratio of -12.32, whereas MDC.AX's P/E ratio is -0.01. In terms of profitability, MSB.AX's ROE is -0.22%, compared to MDC.AX's ROE of +2.75%. Regarding short-term risk, MSB.AX is more volatile compared to MDC.AX. This indicates potentially higher risk in terms of short-term price fluctuations for MSB.AX.
MSB.AX vs BNO.AX Comparison
MSB.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSB.AX stands at 2.20B. In comparison, BNO.AX has a market cap of 13.22M. Regarding current trading prices, MSB.AX is priced at $1.73, while BNO.AX trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSB.AX currently has a P/E ratio of -12.32, whereas BNO.AX's P/E ratio is -0.45. In terms of profitability, MSB.AX's ROE is -0.22%, compared to BNO.AX's ROE of -1.16%. Regarding short-term risk, MSB.AX is less volatile compared to BNO.AX. This indicates potentially lower risk in terms of short-term price fluctuations for MSB.AX.
MSB.AX vs AVE.AX Comparison
MSB.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSB.AX stands at 2.20B. In comparison, AVE.AX has a market cap of 12.69M. Regarding current trading prices, MSB.AX is priced at $1.73, while AVE.AX trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSB.AX currently has a P/E ratio of -12.32, whereas AVE.AX's P/E ratio is N/A. In terms of profitability, MSB.AX's ROE is -0.22%, compared to AVE.AX's ROE of -0.83%. Regarding short-term risk, MSB.AX is more volatile compared to AVE.AX. This indicates potentially higher risk in terms of short-term price fluctuations for MSB.AX.
MSB.AX vs MEM.AX Comparison
MSB.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSB.AX stands at 2.20B. In comparison, MEM.AX has a market cap of 11.90M. Regarding current trading prices, MSB.AX is priced at $1.73, while MEM.AX trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSB.AX currently has a P/E ratio of -12.32, whereas MEM.AX's P/E ratio is N/A. In terms of profitability, MSB.AX's ROE is -0.22%, compared to MEM.AX's ROE of -0.79%. Regarding short-term risk, MSB.AX is less volatile compared to MEM.AX. This indicates potentially lower risk in terms of short-term price fluctuations for MSB.AX.
MSB.AX vs TRP.AX Comparison
MSB.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSB.AX stands at 2.20B. In comparison, TRP.AX has a market cap of 11.79M. Regarding current trading prices, MSB.AX is priced at $1.73, while TRP.AX trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSB.AX currently has a P/E ratio of -12.32, whereas TRP.AX's P/E ratio is -2.79. In terms of profitability, MSB.AX's ROE is -0.22%, compared to TRP.AX's ROE of -0.26%. Regarding short-term risk, MSB.AX is more volatile compared to TRP.AX. This indicates potentially higher risk in terms of short-term price fluctuations for MSB.AX.
MSB.AX vs ACR.AX Comparison
MSB.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSB.AX stands at 2.20B. In comparison, ACR.AX has a market cap of 11.00M. Regarding current trading prices, MSB.AX is priced at $1.73, while ACR.AX trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSB.AX currently has a P/E ratio of -12.32, whereas ACR.AX's P/E ratio is -1.35. In terms of profitability, MSB.AX's ROE is -0.22%, compared to ACR.AX's ROE of -1.79%. Regarding short-term risk, MSB.AX is more volatile compared to ACR.AX. This indicates potentially higher risk in terms of short-term price fluctuations for MSB.AX.
MSB.AX vs NC6.AX Comparison
MSB.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSB.AX stands at 2.20B. In comparison, NC6.AX has a market cap of 10.75M. Regarding current trading prices, MSB.AX is priced at $1.73, while NC6.AX trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSB.AX currently has a P/E ratio of -12.32, whereas NC6.AX's P/E ratio is -4.30. In terms of profitability, MSB.AX's ROE is -0.22%, compared to NC6.AX's ROE of +3.42%. Regarding short-term risk, MSB.AX is less volatile compared to NC6.AX. This indicates potentially lower risk in terms of short-term price fluctuations for MSB.AX.
MSB.AX vs NSB.AX Comparison
MSB.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSB.AX stands at 2.20B. In comparison, NSB.AX has a market cap of 7.52M. Regarding current trading prices, MSB.AX is priced at $1.73, while NSB.AX trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSB.AX currently has a P/E ratio of -12.32, whereas NSB.AX's P/E ratio is 5.20. In terms of profitability, MSB.AX's ROE is -0.22%, compared to NSB.AX's ROE of +0.23%. Regarding short-term risk, MSB.AX is more volatile compared to NSB.AX. This indicates potentially higher risk in terms of short-term price fluctuations for MSB.AX.
MSB.AX vs IXC.AX Comparison
MSB.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSB.AX stands at 2.20B. In comparison, IXC.AX has a market cap of 7.29M. Regarding current trading prices, MSB.AX is priced at $1.73, while IXC.AX trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSB.AX currently has a P/E ratio of -12.32, whereas IXC.AX's P/E ratio is -4.85. In terms of profitability, MSB.AX's ROE is -0.22%, compared to IXC.AX's ROE of +0.02%. Regarding short-term risk, MSB.AX is more volatile compared to IXC.AX. This indicates potentially higher risk in terms of short-term price fluctuations for MSB.AX.
MSB.AX vs CHM.AX Comparison
MSB.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSB.AX stands at 2.20B. In comparison, CHM.AX has a market cap of 7.27M. Regarding current trading prices, MSB.AX is priced at $1.73, while CHM.AX trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSB.AX currently has a P/E ratio of -12.32, whereas CHM.AX's P/E ratio is -0.20. In terms of profitability, MSB.AX's ROE is -0.22%, compared to CHM.AX's ROE of -4.24%. Regarding short-term risk, MSB.AX is less volatile compared to CHM.AX. This indicates potentially lower risk in terms of short-term price fluctuations for MSB.AX.
MSB.AX vs ZLD.AX Comparison
MSB.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSB.AX stands at 2.20B. In comparison, ZLD.AX has a market cap of 5.35M. Regarding current trading prices, MSB.AX is priced at $1.73, while ZLD.AX trades at $0.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSB.AX currently has a P/E ratio of -12.32, whereas ZLD.AX's P/E ratio is -1.07. In terms of profitability, MSB.AX's ROE is -0.22%, compared to ZLD.AX's ROE of +0.75%. Regarding short-term risk, MSB.AX is more volatile compared to ZLD.AX. This indicates potentially higher risk in terms of short-term price fluctuations for MSB.AX.
MSB.AX vs BGT.AX Comparison
MSB.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSB.AX stands at 2.20B. In comparison, BGT.AX has a market cap of 4.63M. Regarding current trading prices, MSB.AX is priced at $1.73, while BGT.AX trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSB.AX currently has a P/E ratio of -12.32, whereas BGT.AX's P/E ratio is -2.30. In terms of profitability, MSB.AX's ROE is -0.22%, compared to BGT.AX's ROE of -1.15%. Regarding short-term risk, MSB.AX is more volatile compared to BGT.AX. This indicates potentially higher risk in terms of short-term price fluctuations for MSB.AX.
MSB.AX vs PAB.AX Comparison
MSB.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSB.AX stands at 2.20B. In comparison, PAB.AX has a market cap of 4.11M. Regarding current trading prices, MSB.AX is priced at $1.73, while PAB.AX trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSB.AX currently has a P/E ratio of -12.32, whereas PAB.AX's P/E ratio is N/A. In terms of profitability, MSB.AX's ROE is -0.22%, compared to PAB.AX's ROE of -1.14%. Regarding short-term risk, MSB.AX is more volatile compared to PAB.AX. This indicates potentially higher risk in terms of short-term price fluctuations for MSB.AX.
MSB.AX vs BIT.AX Comparison
MSB.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSB.AX stands at 2.20B. In comparison, BIT.AX has a market cap of 3.98M. Regarding current trading prices, MSB.AX is priced at $1.73, while BIT.AX trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSB.AX currently has a P/E ratio of -12.32, whereas BIT.AX's P/E ratio is -0.30. In terms of profitability, MSB.AX's ROE is -0.22%, compared to BIT.AX's ROE of -13.17%. Regarding short-term risk, MSB.AX is more volatile compared to BIT.AX. This indicates potentially higher risk in terms of short-term price fluctuations for MSB.AX.
MSB.AX vs VBS.AX Comparison
MSB.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSB.AX stands at 2.20B. In comparison, VBS.AX has a market cap of 3.73M. Regarding current trading prices, MSB.AX is priced at $1.73, while VBS.AX trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSB.AX currently has a P/E ratio of -12.32, whereas VBS.AX's P/E ratio is -1.75. In terms of profitability, MSB.AX's ROE is -0.22%, compared to VBS.AX's ROE of -2.39%. Regarding short-term risk, MSB.AX is less volatile compared to VBS.AX. This indicates potentially lower risk in terms of short-term price fluctuations for MSB.AX.
MSB.AX vs RGS.AX Comparison
MSB.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSB.AX stands at 2.20B. In comparison, RGS.AX has a market cap of 3.68M. Regarding current trading prices, MSB.AX is priced at $1.73, while RGS.AX trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSB.AX currently has a P/E ratio of -12.32, whereas RGS.AX's P/E ratio is -1.20. In terms of profitability, MSB.AX's ROE is -0.22%, compared to RGS.AX's ROE of +4.56%. Regarding short-term risk, MSB.AX is less volatile compared to RGS.AX. This indicates potentially lower risk in terms of short-term price fluctuations for MSB.AX.
MSB.AX vs 1AD.AX Comparison
MSB.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSB.AX stands at 2.20B. In comparison, 1AD.AX has a market cap of 3.22M. Regarding current trading prices, MSB.AX is priced at $1.73, while 1AD.AX trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSB.AX currently has a P/E ratio of -12.32, whereas 1AD.AX's P/E ratio is -0.30. In terms of profitability, MSB.AX's ROE is -0.22%, compared to 1AD.AX's ROE of -4.64%. Regarding short-term risk, MSB.AX is less volatile compared to 1AD.AX. This indicates potentially lower risk in terms of short-term price fluctuations for MSB.AX.
MSB.AX vs HXL.AX Comparison
MSB.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSB.AX stands at 2.20B. In comparison, HXL.AX has a market cap of 2.17M. Regarding current trading prices, MSB.AX is priced at $1.73, while HXL.AX trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSB.AX currently has a P/E ratio of -12.32, whereas HXL.AX's P/E ratio is -1.30. In terms of profitability, MSB.AX's ROE is -0.22%, compared to HXL.AX's ROE of -0.53%. Regarding short-term risk, MSB.AX is more volatile compared to HXL.AX. This indicates potentially higher risk in terms of short-term price fluctuations for MSB.AX.
MSB.AX vs EX1.AX Comparison
MSB.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSB.AX stands at 2.20B. In comparison, EX1.AX has a market cap of 1.93M. Regarding current trading prices, MSB.AX is priced at $1.73, while EX1.AX trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSB.AX currently has a P/E ratio of -12.32, whereas EX1.AX's P/E ratio is -0.12. In terms of profitability, MSB.AX's ROE is -0.22%, compared to EX1.AX's ROE of -1.61%. Regarding short-term risk, MSB.AX is more volatile compared to EX1.AX. This indicates potentially higher risk in terms of short-term price fluctuations for MSB.AX.
MSB.AX vs ANR.AX Comparison
MSB.AX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSB.AX stands at 2.20B. In comparison, ANR.AX has a market cap of 1.07M. Regarding current trading prices, MSB.AX is priced at $1.73, while ANR.AX trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSB.AX currently has a P/E ratio of -12.32, whereas ANR.AX's P/E ratio is -0.50. In terms of profitability, MSB.AX's ROE is -0.22%, compared to ANR.AX's ROE of -1.42%. Regarding short-term risk, MSB.AX is less volatile compared to ANR.AX. This indicates potentially lower risk in terms of short-term price fluctuations for MSB.AX.